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Cell-based therapies in the retina have been associated with the recovery of visual function in animal models of retinal degeneration.
This review covers the current status of such therapies with regard to the source of the donor cells, their integration, and their impact on
the degenerating host retina. Emphasis is also put on the importance of a careful interpretation of what is meant by ‘‘recovery of visual
function’’. Two main approaches are considered here: (1) the use of human embryonic stem cell derived retinal pigment epithelial (RPE)
cells to rescue photoreceptors in an animal model of RPE defect; and (2) the use of photoreceptor precursors to repair the degenerating
neural retina. The current conclusions are that major hurdles have to be dealt with, such as ﬁnding an appropriate and ethically com-
pliant donor cell source that would yield protracted survival and integration of the replacement retinal cells, and that there is no evidence
yet that cell-based therapies can allow the long-term preservation or recovery of conscious vision.
 2007 Elsevier Ltd. All rights reserved.
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Vision is a complex sensory process permitting eye-bear-
ing organisms to detect the features of any object in their
environment such as size, color, orientation, motion, and
distance. The ﬁrst steps in vision take place in the retina,
a thin sheet of neural tissue (approximately 400 lm thick-
ness in humans, and 200 lm in rodents) lining the posterior
pole of the eye. Optical images formed on the retina are
transformed into neural images according to three sequen-
tial stages: (1) transduction of the light signals into electri-
cal changes by the photoreceptors in the outer retina; (2)
synaptic transmission of these electrical changes to cells
in the inner retina; and (3) further synaptic transmission
to retinal ganglion cells, the axons of which collect in the
optic nerve, providing the only output to the brain.
Normal vision requires a healthy eye and retina, i.e. ade-
quate transparency of the optical media, proper lens focus-0042-6989/$ - see front matter  2007 Elsevier Ltd. All rights reserved.
doi:10.1016/j.visres.2007.06.018
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E-mail address: ysauve@ualberta.ca (Y. Sauve´).ing upon the retinal plane, intact retinal organization and
an eﬃcient blood vessel network. Damage to any of these
structures can lead to visual impairment with blindness as
the end result.2. Loss of vision: Etiology
Vision loss aﬀects approximately 3.4 million US citizens
over the age of 40; and this number is expected to increase
twofold in the next three decades. The leading causes of
blindness in the US are cataract (17.2%) and various forms
of retinal degeneration, namely aged-related macular
degeneration (AMD; 7.6%), diabetic retinopathy (DR;
3.4%), glaucoma (1.9%) and retinitis pigmentosa (RP;
0.34%) (online data available from National Eye Institute
website: http://www.nei.nih.gov/eyedata/pbd_tables.asp).
With the exception of glaucoma (where ganglion cells die
due to the compression of their axons), and some forms
of vitreoretinal degenerations (aﬀecting the inner retina
ﬁrst), most retinal degenerations are characterized by the
progressive loss of photoreceptor cells initially aﬀecting pri-
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mary defects located either in the RPE cells (playing an
essential role for photoreceptor function and survival) or
the photoreceptors themselves.
3. Therapeutic approaches designed to rescue or repair the
degenerating retina
Over the last 25 years, several therapeutic approaches
have been designed to delay the pathological processes
leading to blindness. Some of them are summarized in
Table 1. While a few of these treatments are currently used
in the clinic (essentially surgical approaches, with limited
success), most are still in their infancy or at best at the
pre-clinical trial (phase 1) level.
Recently, two experimental approaches received consid-
erable media coverage emphasizing the promise of relying
on cell-based therapies to rescue degenerating retinas in
humans. The ﬁrst approach consisted of using RPE cells
derived from multiple human embryonic stem cell lines as
a mean to improve photoreceptor survival in an animal
model of RPE defect, the Royal College of Surgeons
(RCS) rat (Lund et al., 2006). The second approach con-
sisted of studying the ability of neonatal photoreceptor pre-
cursors to diﬀerentiate and integrate into the outer nuclear
layer (ONL) in both the intact and the degenerating retina
of mature mice (MacLaren et al., 2006).
Taking these ﬁndings into consideration, this review
addresses the potential and limitations of current experi-
mental cell-based therapies for blindness, while keeping
in mind that in order to be successful, cell therapy should
fulﬁll four fundamental criteria. The desired cells should:
(1) multiply in suﬃcient quantities, (2) organize into func-
tional units, (3) survive and integrate into the host, and
ultimately, (4) lead to the preservation of vision without
causing deleterious side eﬀects.
4. Using human embryonic stem cell-derived RPE cells to
rescue photoreceptors in the RCS rat
The RCS rat is a widely used model of retinal degener-
ation in which a mutation of the receptor tyrosine kinase
mertk gene (D’Cruz et al., 2000) precludes RPE cells from
phagocytosing outer segment debris, leading ultimately to
the death of healthy photoreceptors within a three-monthTable 1
Therapeutic approaches
Therapeutic approach Model
Vitreoretinal surgery Neovascular AMD diabetic r
Pharmaceutical (CNTF) Retinal degenerations
Functional electrical stimulation Retinitis pigmentosa
Gene therapy Neovascular AMD
Interference RNA Retinal degenerations
Cell based therapy: diﬀerentiated cells AMD
Cell based therapy: stem cells Retinal degenerations
*A review.period. Morphological changes in photoreceptor outer seg-
ments appear as early as P16 (when the eyes open), and by
P120 only scattered photoreceptor cells (cones) remain.
Mutations in the human mertk gene cause a rare form of
RP: a total of four patients has been reported in the liter-
ature (Gal et al., 2000; McHenry et al., 2004).
Ideally, the ultimate cell-based therapy, aimed at pre-
serving photoreceptor function in this model, would be
the replacement of the defective cells by RPE cells resuming
a normal function in the host (for a review see Lund et al.,
2001). There is recent evidence that many ethically accept-
able sources of multipotent human stem cells can reliably
be induced to diﬀerentiate into cells having numerous
RPE-speciﬁc genes and phagocytic function in vitro (Kli-
manskaya et al., 2004). Moreover, RPE cells derived from
human embryonic stem cells have been reported to ‘‘rescue
visual function’’ when injected into the subretinal space of
RCS rats at an age when photoreceptor cell death begins
(Lund et al., 2006); we will address the meaning of ‘‘visual
function’’ later. In parallel with the need to develop further
embryonic stem cell-related strategies to treat RPE-based
retinal degeneration, crucial issues must be elucidated prior
to considering clinical trials.4.1. Limited integration of the donor cells in the host
Despite their ability to form a monolayer with cobble-
stone morphology in vitro (Klimanskaya et al., 2004),
grafted human embryonic stem cell-derived RPE cells
remain aggregated in the subretinal space at the injection
site, and are incapable of forming a monolayer over the
defective RPE. This failure has three direct consequences:
ﬁrst, photoreceptor rescue covers a limited area of the ret-
ina (optimal in the graft sector but comparable to dystro-
phic levels in remote areas, 1 mm away from the graft
border); second, the host retina is locally pushed toward
the lens, implying a strong defocussing (hypermetropia-
like) and distortion of the retinal images in the rescued
area; and third, the persistence of cell aggregates might
cause deleterious eﬀects analogous to the ones seen after
retinal detachments, such as causing photoreceptor death
and extensive retina remodeling (for a review see Fisher,
Lewis, Linberg, & Verardo, 2005). In theory, a series of
concomitant injections would be needed in order to rescue
photoreceptors over the whole retina. Such a strategy,Reference
etinopathy Conti and Kertes (2005)*, Joussen and Joeres (2007)
Sieving et al. (2006)
Yanai et al. (2007)
Campochiaro et al. (2006)*
Cashman, Binkley, and Kumar-Singh (2005)*
Algvere, Berglin, Gouras, Sheng, and Kopp (1997)
Limb et al. (2006)*
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cal deformations of the retina (‘‘waﬄed retina’’) and asso-
ciated compound distortions of the visual image
(metamorphopsia) in addition to the ultimate risk of retinal
detachments.
The above-mentioned side eﬀects are readily observed
with human Schwann (hSC) cells, but seem absent with
human RPE (hRPE) cell lines including ARPE-19 (Lund
et al., 2001). While the former remain aggregated into sev-
eral clumps, the latter progressively forms a monolayer,
covering signiﬁcant retinal area by 15 weeks after injection
(Wang, Lu, Wood, & Lund, 2005). Of note, the hRPE-
derived cell lines studied so far display structural properties
(cell polarization, intercellular tight junctions and barrier
function) characteristic of native RPE cells (Dunn,
Aotaki-Keen, Putkey, & Hjelmeland, 1996; Kanuga
et al., 2002). Potentially, in situ layering could be cell-type
speciﬁc, while independent of xenograft conditions. Fur-
ther studies are therefore required to examine whether
human embryonic stem cell-derived RPE cells have mor-
phological specializations of RPE cells and redistribute
over the retina at increasing post-grafting time points.
However, understanding the reasons why both cell lines
fail to rapidly expand into the subretinal space might be
even more critical as a step toward achieving successful
cell-based therapies. The speciﬁc factors to consider include
the inﬂuence of: (1) tropic factors in guiding the expansion
of donor cells, (2) the interaction between extracellular
matrix proteins and their respective integrin receptors, (3)
toxic debris produced by shed outer segments and dying
donor cells, (4) the defective host RPE on the growth
and division of the donor cells (RPE cells contain high lev-
els of retinoids, which are known to be able of inhibiting
cellular division; Campochiaro, Hacket, & Conway,
1991), (5) mechanical constraints due to the close apposi-
tion of the photoreceptor outer segments with the RPE
cells, and (6) both host and donor cell motility. Of note,
some of these above-mentioned inﬂuences might be
bypassed by surgical techniques designed to allow the
deposition of already formed cellular monolayers along
the host subretinal space (Seiler & Aramant, 2005). More-
over, although limited by the host photoreceptors them-
selves (Zhang, Arner, Ehinger, & Perez, 2003), the
integration of such monolayers into the host may be
improved by concomitant pharmacological modulations
of the extracellular matrix (Suzuki, Mandai, Akimoto,
Yoshimura, & Takahashi, 2006).
4.2. Mode of action of the donor cells: a paracrine eﬀect
Photoreceptor rescue ultimately requires the phagocyto-
sis of outer segment shed debris and the release of trophic
factors by the donor cells. While freshly harvested allogeneic
RPE cells can resume in vivo the phagocytic function
(Lavail, Li, Turner, & Yasumura, 1992), it is unclear
whether this is also true for the embryonic stem cell-derived
RPE cells in vivo. For a clear conﬁrmation that resumedphagocytosis does contribute to the reported rescue in
RPE transplantation studies, subretinal injection of an
RPE cell line having themertkmutationmust be undertaken
in the RCS rat. Without this crucial experiment, the current
evidence supports a paracrine survival eﬀect: (1) hRPE cell
lines used for transplantation express and release trophic
factors that are essential for photoreceptor survival (Kanu-
ga et al., 2002); (2) anatomical observations of retinas as well
as visual response recordings from the CNS both indicate
that the area of rescue largely exceeds the retina areas with
persisting donor cells; (3) subretinal transplantation of cells
incapable of phagocytosis, including hSC cells, umbilical tis-
sue-derived cells, placenta-derived cells, and to a lesser
degree, bone marrow-derived mesenchymal stem cells,
yields very similar results as with RPE transplantation
(Lawrence et al., 2004; Lund et al., 2007; Wang et al.,
2005; and (4) photoreceptor rescue has been observed with
human fetal ﬁbroblasts engineered to produce CNTF
(Huang et al., 2006) as well as with human cortical progen-
itors that release IGF-1 and FGF-2 (Gamm et al., 2007). A
paracrine action might also underlie the results reported by
Lund et al. (2006), since the anatomical rescue widely
exceeds the area containing the transplanted human embry-
onic stem cell-derived RPE cells. These cells express, among
other trophic factors, the PEDF gene and protein (Klimans-
kaya et al., 2004), a trophic factor known to have protective
and morphogenetic eﬀects on photoreceptors (Aymerich,
Alberdi, Martinez, & Becerra, 2001; Barnstable & Tom-
bran-Tink, 2004; Cayouette, Smith, Becerra, & Gravel,
1999; Imai, Yoneya, Gehlbach, Wei, & Mori, 2005). There-
fore there is yet no clear evidence that the observed retinal
rescue by grafted human embryonic stem cell-derived RPE
cells is mediated via their ability to correct the primary phag-
ocytic defect that occurs in RCS rats.
In fact, the paracrine delivery of trophic factors in cell-
based therapies appears to have a generalized rescue eﬀect
that is independent of the primary genetic defect. For
instance, transplantation of rods in rodless mice can halt
the secondary death of cones via the delivery of a rod-
derived cone viability factor (Mohand-Said, Hicks, Drey-
fus, & Sahel, 2000; Leveillard et al., 2004). A further exam-
ple comes from dogs deﬁcient for PDE6-beta and S334-ter
rats in which photoreceptors could be rescued with the ocu-
lar transplantation of a human retinal cell line engineered
to produce CNTF (Tao et al., 2002). Lastly, Keegan
et al. (2003) showed that photoreceptors could be rescued
in rho/ mice by injecting in their subretinal space Schw-
ann cells, which were shown to produce several factors
such as CNTF and BDNF.
While the paracrine delivery of survival factors by
grafted cells appears suﬃcient to rescue photoreceptors,
this eﬀect rapidly fades away in all models studied. At 6
weeks post-injection, electroretinogram responses (which
reﬂect the summation of activity from the whole retina)
recorded from RCS retinas having received human embry-
onic stem cell-derived RPE cells are signiﬁcantly larger
than in sham-injected retinas, but undergo severe impair-
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cell lines (Sauve´, Pinilla, & Lund, 2006). Such functional
deteriorations over time are also evidenced by other tests
involving CNS visual responsiveness and visually guided
behaviors (Girman, Wang, & Lund, 2005; McGill et al.,
2004). These declines can be attributed in part to the mas-
sive death of the donor cells. Less than 2% of the initially
delivered ARPE-19 cells persist in the host subretinal space
at 15 weeks post-injection, some (0.2%) being still present
at 7 months post-injection (Wang et al., 2005). Neverthe-
less, by this age, the persistence of a few ARPE-19 cells is
associated with the rescue of some photoreceptors only
over very small retinal areas while virtually no photorecep-
tors are detected in age-matched dystrophic rats. Further-
more, these areas are associated with the visual
responsiveness of individual neurons in the primary visual
cortex (Girman, Wang, & Lund, 2003). Whether such cir-
cumscribed retinal areas of rescue alone are responsible
for the limited preservation of visual acuity as evaluated
with tests such as head tracking (Coﬀey et al., 2002) and
visual ‘‘y’’ water maze (McGill et al., 2004) is unknown.
Finally, whether human embryonic stem cell-derived RPE
cells lead to better rescue than the RPE cell line ARPE-
19 isolated from an adult human is also unknown.
4.3. Manipulating stem cells or improving surgery?
The main rationale given for using human embryonic
stem cell lines over adult-derived RPE cell lines is the abil-
ity to produce diﬀerentiated RPE cells in vitro, while open-
ing the possibility of manipulating the cells to render them
less immunogenic. Other advantages include the ability to
maintain pathogen-free non-diﬀerentiated cells in culture
with the ﬂexibility of expanding large quantities on
demand. In this regard, the key issues are the following:
(1) whether the donor cells must possess an RPE phenotype
to produce the reported rescue eﬀects and (2) whether
human embryonic stem cells are the optimal cell source.
The transplantation of mature cells, which are not RPE
in phenotype, such as syngeneic Schwann cells (Lund
et al., 2007; McGill et al., 2007) can yield similar beneﬁcial
outcomes as obtained with human embryonic stem cell-
derived sources. Moreover, since the therapeutic eﬃcacy
of donor cells appears to rely on a paracrine eﬀect, then,
the essential aims would be the production of trophic fac-
tors by the transplanted cells. Indeed, in addition to adult
syngeneic Schwann cells, numerous cell sources, that are
non-immunogenic and easily available, have been success-
fully used to rescue retina function in RPE-based retina
degenerations. The possibility remains to manipulate these
other cell types to produce trophic factors and to minimize
rejection. As such, the transfection of autologous sources
would be optimal. However, since paracrine-based rescue
have short lasting eﬀects, multiple cell injections would be
required. Such an endeavor would be laborious, costly,
and unfeasibly scaled up. Furthermore, even assuming that
a constant level of trophic factors can be maintained, thereis no evidence that this alone would preserve photorecep-
tors indeﬁnitely if the primary defect itself is not corrected.
An additional complication that must be considered
when doing subretinal cell injections is the formation of a
donor cell layer on the dysfunctional host RPE cells. A
potential strategy could involve a debridement of the defec-
tive RPE layer. It has been shown that bone marrow-
derived cells are able to home and regenerate the host
RPE after acute injuries (Harris et al., 2006); and that a
de novo RPE growth occurs after local debridement (Del
Priore et al., 1993; Valentino et al., 1995). However, this
procedure presents disadvantages: (1) it induces an addi-
tional lesion that needs to be precisely controlled; (2) it
might enhance the probability of graft rejection due to a
breach in the blood-retina-barrier which normally protects
the retina from systemic immune inﬂuences; (3) it might
produce a pathological migration of RPE cells as seen in
proliferative vitreoretinopathy (for a review see Layer,
Rothermel, & Willbold, 2001). Nevertheless, the validity
of a precisely controlled debridement of the defective
RPE is worth exploring in models with intrinsically defec-
tive RPE cells, such as the RCS rats before implantation of
RPE-like cells.
4.4. Limitations of the RCS rat as a model of photoreceptor
degeneration and relevant therapies
The RCS rat, being a model of secondary photoreceptor
degeneration, is not consistent with most forms of RP. The
majority of the genes found to cause RP are expressed in
the photoreceptors (for an update see: http://
www.sph.uth.tmc.edu/Retnet/). The genetic defect in
RCS rats precludes RPE cells from phagocytosing photore-
ceptor outer segments, which leads to the accumulation of
debris in the subretinal space. These debris create a barrier
to oxygen and nutrient diﬀusion from the RPE to photore-
ceptors. Subretinal injections disrupt and wash such debris.
Therefore, the larger the area washed with the injection, the
larger should be the area of photoreceptor rescue. In agree-
ment with this hypothesis, quantifying the area of retina
detachment funduscopically (immediately after the sur-
gery) is a common way of assessing the success rate of
the injections. Local areas of functional rescue (preserva-
tion of visual sensitivity) can be observed in RCS rats up
to 6 months after sham injections (consisting of saline or
culture medium without any cells; Sauve´, Girman, Wang,
Keegan, & Lund, 2002); these rescue areas are proportional
to the size of detachment assessed immediately after the
injections. Similar sham eﬀects are not observed in the
P23H rat, a model with primary photoreceptor degenera-
tion (Y. Sauve´, unpublished observations).
5. Using photoreceptor precursors to repair the degenerating
neural retina
Repairing the neural retina is a much more complex task
than that of replacing the RPE. Retina repair implies, in
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of an atrophied and severely remodeled retina (reviewed
in Jones & Marc, 2005) by speciﬁc cell types having a pre-
cise anatomical arrangement, complex synaptic patterns
and highly specialized individual functions (for a review
of retina circuitry, go to: http://webvision.med.utah.edu/).
In essence, the task involves using donor cells to recon-
struct a complex neural network in an environment in
which an unpredictable number of neurons of equally
unpredictable subtypes have died and the persisting circuit
has changed radically.
At the early stages of the degenerative process, replacing
defective photoreceptors is likely suﬃcient to maintain nor-
mal retinal function providing that the donor cells can
establish functional synapses on appropriate second order
neurons, and that these second order neurons have not
yet undergone synaptic remodeling other than with the lost
photoreceptors. The functional changes ensuing from the
progressive loss of photoreceptors represent substantial
hurdles that will be addressed below.
5.1. What is the appropriate cell source?
As is the case with RPE replacement, a critical aspect in
the present approach rests on obtaining reliable and ethi-
cally acceptable sources of photoreceptor cells. Various
sources have been studied in this respect: dissociated adult
photoreceptors (Gouras et al., 1991a), micro-aggregates of
developing photoreceptors (Gouras, Du, Kjeldbye,
Yamamoto, & Zack, 1994; Gouras & Tanabe, 2003), pieces
of whole retinal tissue (Sharma, Bergstrom, Zucker,
Adolph, & Ehinger, 2000), photoreceptor sheets (Berger,
Tezel, Del Priore, & Kaplan, 2003) and more recently, stem
or progenitor cells of various origin (Canola et al., 2007;
Guo, Saloupis, Shaw, & Rickman, 2003; MacLaren et al.,
2006; Meyer, Katz, Maruniak, & Kirk, 2006; Nishida
et al., 2000; Pressmar, Ader, Richard, Schachner, & Bart-
sch, 2001; Sakaguchi, Van Hoﬀelen, & Young, 2003;
Young, Ray, Whiteley, Klassen, & Gage, 2000). The major
ﬁndings, regardless of the cell source, are that the donor
cells (once transplanted into the host subretinal space) lack
at least one of the essential characteristics of diﬀerentiated
photoreceptors: formation of inner and outer segments,
orderly array in the outer nuclear layer, adequate synaptic
contacts with inner retinal neurons, or expression of spe-
ciﬁc adult photoreceptor markers.
Recent ﬁndings (MacLaren et al., 2006) showed that
subretinal injection of dissociated retinal allogeneic donor
cells harvested between embryonic day 16.5 (E16.5) and
post-natal day 11 (P11) can achieve several requirements
to replace photoreceptors: (1) successful integration in the
ONL of both normal and degenerating adult mouse reti-
nas, (2) correct orientation, (3) adequate morphology, (4)
synapse formation and (5) expression of key factors
involved in the phototransduction process. The success rate
was optimal for cells harvested at ages P3–P7. Within this
narrow developmental time window, these cells are post-mitotic immature precursors engaged in a rod fate as indi-
cated by the expression of the Nrl (neural retina leucine
zipper) transcription factor. In contrast, once subretinally
injected, Nrl-negative, still proliferating embryonic progen-
itors as well as adult Nrl-positive cells remain within the
subretinal space. Moreover, though representing at best
0.1% of the grafted cells, the newly diﬀerentiated photore-
ceptor-like cells are associated with some level of visual
function preservation in the dystrophic host.
5.2. Technical limitations
With the ultimate goal of translating such ﬁndings into
potential therapies, several crucial points must be
addressed. A ﬁrst limitation deals with the status of the
extremely large number of cells (four to 40 times more than
with RPE injections) introduced into the subretinal space
of mature hosts, and which, for the most part (99.9%),
do not integrate into the ONL and remain in the subretinal
space. Part of these non-integrating cells originates from
proliferating progenitors that have achieved maturation
after transplantation. The factors aﬀecting how this large
number of donor cells distributes over post-injection time
in the host subretinal space remain to be elucidated. First,
in the eventuality of long term persistence of rosette-like
structures or multilayered sheets in the subretinal space,
then, similar side eﬀects as mentioned above in cases of
RPE transplantation experiments must be considered: ret-
inal detachments with severe consequences on the host ret-
ina (for a review see Fisher et al., 2005) and optical
aberrations due to distortions of the retina. Second, infor-
mation on the topographic scattering of the donor cells
with respect to the injection site is essential when consider-
ing whether multiple injections might achieve full ﬁeld
visual coverage. The development of successful therapies
also entails the clariﬁcation of several other issues such as
understanding: (1) whether some cells grafted as progeni-
tors adopt a non-photoreceptor phenotype and invade
the inner retina (Klassen et al., 2004), and (2) how the
physiological state of the host retina (degenerated and
therefore remodeled in the case of reconstructive
approaches) might impact on the fate of the donor cells
(Klassen et al., 2004); as long as the primary defect itself
is not corrected, the host retina is bound to undergo con-
stant changes by virtue of the ongoing progressive degener-
ative and reactive events taking place.
5.3. What is the optimal developmental stage of the donor
cells?
Adequate phenotype and successful integration into the
ONL appears to be limited to Nrl-expressing precursors.
Nrl is a speciﬁc marker for cells committed to a rod-speciﬁc
phenotype. It has been proposed to be a critical develop-
mental molecular switch that promotes the expression of
rod-speciﬁc genes while inhibiting cone-speciﬁc genes
(Mears et al., 2001 Oh et al., 2007). Nrl/ mice have a ret-
2820 F. Gaillard, Y. Sauve´ / Vision Research 47 (2007) 2815–2824ina in which photoreceptors consist essentially of cones
(Daniele et al., 2005). In contrast, ectopic expression in
wildtype and Nrl/ mutants leads to an essentially rod-
dominated retina (Oh et al., 2007). In the normal mouse,
Nrl expression is ﬁrst detected at E12.5. Cones diﬀerentiate
before rods (respectively, between E10-E19 and E13-P8)
depending on their center to periphery location in the ret-
ina (Carter-Dawson & LaVail, 1979). In addition to undif-
ferentiated progenitor and post-mitotic rods, the youngest
successful grafts (E16.5-P1) used by MacLaren et al. (2006)
have therefore to consist of cones having just achieved their
last mitosis. The negative results obtained with E11.5
donor tissue suggest that cone integration also requires
post-mitotic cells. However, following subretinal delivery
of P1 donor tissue, only very few cone-like proﬁles were
found to integrate into the host ONL. For such an
approach to be employed for the replacement of the defec-
tive human photoreceptor layer (consisting of 5–6% cones
throughout the retina and of 100% cones in the fovea),
more information is required on how to generate cone-like
cells once subretinally injected. Several questions arise: (1)
could a greater number of cones be generated in the host by
selecting younger donors (for instance E13-E16)? (2) is
there a speciﬁc developmental window that would allow a
nearly normal ratio between integrated donor cones and
donor rods? and (3) is the mouse retina (2–3% cones vs.
97–98% rods) a suitable model for such studies or would
diurnal species provide more relevant models?
One further important point to consider is that only the
cells that have acquired a rod fate in a normal environment
appear to be able to develop normal rod morphology and
to integrate into the ONL of the adult host retina. Once
injected into the subretinal space of the host where they
achieve Nrl expression, young (E11.5) proliferating pro-
genitors are incapable of doing so. Similar ﬁndings have
been obtained with older (E17) progenitor cells that were
experimentally maintained undiﬀerentiated under speciﬁc
in vitro conditions (Chacko, Rogers, Turner, & Ahmad,
2000; Yang, Seiler, Aramant, & Whittemore, 2002), as well
as with fully mature photoreceptors (Gouras et al., 1991b;
MacLaren et al., 2006). In other words, morphogenesis and
ONL integration would require extrinsic inﬂuences present
around birth in the developing donor retina (Klassen et al.,
2004). Preservation of some of these native interactions
might explain in part why photoreceptors derived from
P1-P9 retinal microaggregates develop nearly normal outer
segments when grafted in the adult rodless rd mouse (Gou-
ras & Tanabe, 2003; Gouras et al., 1994; Kwan, Wang, &
Lund, 1999) while age-matched dissociated cells do not
(MacLaren et al., 2006). Whether the re-expression of such
crucial developmental factors (Zacks, Han, Zeng, & Swa-
roop, 2006) might promote the diﬀerentiation of dissoci-
ated precursors into photoreceptors and their integration
into the ONL of normal and degenerating retinas deserves
consideration.
If indeed post-mitotic Nrl-expressing homologs are the
ideal candidates for the successful replacement of degener-ating rod photoreceptors, then two major hurdles must be
considered. First, if we assume that a developing stage of
P3–P5 in rodents corresponds approximately to the second
trimester of gestation in human embryos (Nrl and rod
opsin proteins are not detected until embryonic weeks 11
and 15–16, respectively; O’Brien, Schulte & Hendrickson,
2003), then an inherent ethical concern must be addressed
when considering human therapies. The very few clinical
trials that have been performed with such committed
embryonic cells are up to now inconclusive (Del Cerro
et al., 2000). However, this is most likely in part due to
the likelihood that the patients recruited in these studies
had no functional RPE to allow the photoreceptor precur-
sors to develop normally (Gouras et al., 1994). Second, if
there is indeed such a late time window, then it further pre-
cludes the use of ES-derived cells as a source for replacing
degenerating photoreceptors, except if these cells can be
managed in vitro up to an advanced stage of neural retina
diﬀerentiation. Allogeneic neonatal retinal stem cells
derived from the radial glial population have practically
no potential for replacing degenerating photoreceptors in
mice (Canola et al., 2007). Diﬀerentiated human embryonic
stem cell-derived neural precursors express transcripts
characteristic of mature photoreceptors (recoverin, Nrl,
rhodpsin and S-cone opsin), but fail to express these very
proteins (Banin et al., 2006). Protein expression by these
precursors has been observed either in vitro after treatment
with TGF-b3 (Dong, Pulido, Qu, & Sugaya, 2003) or
in vivo after implantation into the subretinal space of both
normal neonate and adult rats. In the latter case, appropri-
ate protein expression occurred in only very few (approxi-
mately 1.5%) of the grafted cells, and these were
morphologically abnormal (Banin et al., 2006). Basic
research is therefore essential to determine how to induce
human embryonic stem cell diﬀerentiation into fully com-
petent photoreceptor precursors. A recent report indicates
that under very speciﬁc culture condition, it is indeed pos-
sible to obtain Nrl-expressing cells from human embryonic
stem-cell lines (Lamba, Karl, Ware, & Reh, 2006). Whether
these cells can resume the function of Nrl+ mouse rod pho-
toreceptors once transplanted into the degenerating host
retina remains to be determined.
6. Functional assessment of cell-based therapies
The anatomical preservation of photoreceptors does not
guarantee the preservation of visual function. Instances
exist where retinal structure but not function is preserved
using pharmacological approaches in animal models of
RP where the genetic defect is in the photoreceptors (Bok
et al., 2002; Green et al., 2001; Liang et al., 2001). The pres-
ervation of visual function can be interpreted in various
ways depending of what is meant by ‘‘visual function’’. If
visual function implies conscious vision, then it requires
the activation of several cortical areas, encoding various
aspects of the visual scene. Assuming that photoreceptors
retain their phototransduction capacity, there must be acti-
F. Gaillard, Y. Sauve´ / Vision Research 47 (2007) 2815–2824 2821vation of the retina circuits culminating in the encoding by
speciﬁc RGCs (in terms of action potentials of various tem-
poral frequencies) of the many modalities contained in the
visual scene. These speciﬁc modalities must then be sent to
speciﬁc projection centers specialized in the analysis of
these speciﬁc modalities (color, motion, recognition of
complex shapes, etc). Visual function can also be uncon-
scious such as in the pupillary light reﬂex, nystagmus, head
turning behaviors and photophobia. In the case of the
pupillary light reﬂex, it can be elicited by intrinsically pho-
tosensitive RGCs, bypassing the need for phototransduc-
tion by photoreceptors and downstream activation of
retina circuits (Fu et al., 2005). Therefore, when assessing
therapeutic outcomes of any therapies in the visual system
it is essential to clearly deﬁne which aspect of visual func-
tion is being evaluated and what relevance it has to poten-
tial therapeutic beneﬁts.
For example, let us consider how to demonstrate
improved visual function in rho/ mice with subretinally
injected progenitor cells (MacLaren et al., 2006). Two tests
were used in this seminal study: pupillary light reﬂex and
ﬁeld potentials from the RGC layer in superfused retinal
whole mounts. Since rho/mice retain cone function, test-
ing for potential restoration of rod function requires prov-
ing that visually elicited responses can be obtained with a
stimulus of intensity below cone thresholds. Such demon-
stration is crucial if the cells to be replaced consist of rods.
Using both tests, the light levels required to elicit responses
were lower in mice having received the progenitors but not
sham injections. What do these results imply in term of
visual function? If the term ‘‘visual function’’ is associated
with the occurrence of pupillary light reﬂex, it must be clear
that this visual function represents an unconscious event.
Furthermore, the possibility that photoreceptors are not
required for eliciting this reﬂex cannot be excluded (Fu
et al., 2005). In the case of ﬁeld potentials recorded from
the RGC layer in superfused retinas, such activity does
not conﬁrm the activation of CNS visual centers. In con-
clusion, a relative increase in the sensitivity of the pupillary
light reﬂex as well as visually elicited ﬁeld potential
responses from isolated retinas do indicate a better
sensitivity to ambient light levels; however, interpretation
of these results as ‘‘improved visual function’’ can be
misleading.
Use of the electroretinogram can provide useful infor-
mation with regard to light-driven photoreceptor activity
(leading edge of the a-wave) and post-synaptic activation
of the retina circuitry (b-wave and oscillatory potentials).
However, the electroretinogram requires the summation
of activity from the whole retina and can be ﬂat when only
small areas of the retina process visual information. One
mean of detecting activity from these small areas is to elec-
trophysiologically record multi-unit activity from discrete
areas of the superior colliculus where over 95% of the
RGC axons project contralaterally and do so in a retino-
topic fashion. In this manner, a sensitivity map of the ret-
ina can be derived (Sauve´ et al., 2002). This approach isparticularly pertinent to cell-based therapies where only
conﬁned areas of the retina might be rescued. However,
the ultimate proof of activation of CNS centers mediating
conscious vision must come from either recording electro-
physiological activity from visual cortical areas (Girman
et al., 2003) or doing cortically mediated behavioral tests
such as the visual ‘‘y’’ water maze described by the group
of G. Prusky (McGill et al., 2004).7. Conclusion
Several issues are unresolved with regard to the clinical
translation of cell-based therapies for retina repair. There is
no technology yet to initiate the diﬀerentiation of embry-
onic stem cells into fully competent precursors capable of
replacing defective photoreceptors. Further investigations
are needed to identify the factors and conditions required
to induce in vitro the diﬀerentiation of embryonic stem cells
into fully competent photoreceptor precursors: the harvest-
ing of such precursors at mid-embryonic stages is ethically
not acceptable. Assuming that an appropriate source of
diﬀerentiated cells could be generated and furthermore
could repopulate the host retina, then it is fundamental
to prove that these cells will not form any retinoblas-
toma-like tumors over the long term (Arnhold, Klein,
Semkova, Addicks, & Schraermeyer, 2004; Hara et al.,
2004) and that they can retain their photoreceptor charac-
teristics while remaining anatomically and functionally
integrated in the various and continually changing environ-
mental conditions that typify degenerating retinas. The
same requirements apply to replacing cells other than pho-
toreceptors. One exception appears to be the cases of RPE-
based retina degenerations. While neither human embry-
onic stem cells nor human RPE-derived cells display basic
RPE cell properties when grafted subretinally in the actual
surgical conditions, the production of trophic factors by
the donor cells could alone mediate their therapeutic bene-
ﬁts. There is overwhelming evidence that optimal preven-
tion of retinal degeneration (both anatomically and
functionally) can be achieved with subretinal injections of
cells that are readily available, safe, ethically acceptable
and derived from sources other than from embryonic stem
cells such as adult RPE cells line or adult syngeneic Schw-
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